Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Intrinsic Value
The intrinsic value of one Hansoh Pharmaceutical Group Company Ltd stock under the Base Case scenario is 17.89 HKD. Compared to the current market price of 22.1 HKD, Hansoh Pharmaceutical Group Company Ltd is Overvalued by 19%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Hansoh Pharmaceutical Group Company Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Hansoh Pharmaceutical Group Company Ltd
Balance Sheet Decomposition
Hansoh Pharmaceutical Group Company Ltd
Current Assets | 27.4B |
Cash & Short-Term Investments | 23.4B |
Receivables | 3.2B |
Other Current Assets | 885.8m |
Non-Current Assets | 4.2B |
Long-Term Investments | 702.3m |
PP&E | 3.3B |
Intangibles | 245.3m |
Free Cash Flow Analysis
Hansoh Pharmaceutical Group Company Ltd
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
Hansoh Pharmaceutical Group Company Ltd
Revenue
|
12.3B
CNY
|
Cost of Revenue
|
-1.1B
CNY
|
Gross Profit
|
11.2B
CNY
|
Operating Expenses
|
-6.1B
CNY
|
Operating Income
|
5.1B
CNY
|
Other Expenses
|
-685m
CNY
|
Net Income
|
4.4B
CNY
|
Profitability Score
Profitability Due Diligence
Hansoh Pharmaceutical Group Company Ltd's profitability score is 75/100. The higher the profitability score, the more profitable the company is.
Score
Hansoh Pharmaceutical Group Company Ltd's profitability score is 75/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Hansoh Pharmaceutical Group Company Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Score
Hansoh Pharmaceutical Group Company Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Hansoh Pharmaceutical Group Company Ltd
According to Wall Street analysts, the average 1-year price target for Hansoh Pharmaceutical Group Company Ltd is 25.29 HKD with a low forecast of 20.06 HKD and a high forecast of 33.6 HKD.
Dividends
Current shareholder yield for Hansoh Pharmaceutical Group Company Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one Hansoh Pharmaceutical Group Company Ltd stock under the Base Case scenario is 17.89 HKD.
Compared to the current market price of 22.1 HKD, Hansoh Pharmaceutical Group Company Ltd is Overvalued by 19%.